The fact
This approach aims to improve survival rates, which are currently very low for this disease.
Clinical trials could begin within two years if preclinical results are confirmed.
Click the link to read an article on the topic:
This approach aims to improve survival rates, which are currently very low for this disease.
Clinical trials could begin within two years if preclinical results are confirmed.